Shil Patel

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

S. Sathyanarayanan, O. Burenkova, S. Jang, 2022, Science advances.

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis

S. Hannenhalli, R. Kaplan, J. Drake, 2021, Cell.

Esophageal extracellular matrix hydrogel mitigates metaplastic change in a dog model of Barrett’s esophagus

Jenna L. Dziki, S. Badylak, K. Hansen, 2020, Science Advances.

Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype.

N. Turner, S. Badylak, L. Huleihel, 2019, Tissue engineering. Part A.